For clinicians caring for patients with diabetes, pressure wounds represent a distinct and persistent clinical challenge. Compared to non-diabetic populations, pressure injuries in diabetic patients develop more readily, progress more rapidly, and heal more slowly. These differences are not incidental—they are rooted in well-documented pathophysiology, including neuropathy, microvascular disease, and impaired inflammatory response.
Support surfaces are a critical—but frequently misunderstood—component of pressure wound prevention and treatment in this population. This article reframes support surface selection through the lens of pressure wounds in diabetic patients, clarifies what clinical evidence supports, addresses common misconceptions found in non-clinical sources, and explains how alternating pressure systems align with established standards of care.
Why are diabetic patients uniquely vulnerable to pressure wounds?
Diabetes fundamentally alters tissue tolerance to mechanical loading. Several interrelated factors increase both the risk and severity of pressure wounds:
- Peripheral neuropathy reduces protective sensation, allowing prolonged unrelieved pressure
- Microvascular disease limits oxygen and nutrient delivery at the capillary level
- Impaired inflammatory and angiogenic response delays tissue repair
- Skin fragility and moisture imbalance increase susceptibility to breakdown and maceration
In diabetic patients, pressure wounds are rarely the result of interface pressure alone. Instead, microclimate and moderate mechanical forces acting over time can precipitate tissue ischemia and necrosis when perfusion reserves are limited.
Pressure redistribution as a standard-of-care principle
Clinical literature consistently emphasizes that pressure redistribution—not pressure elimination—is the primary goal of support surface therapy.
No support surface can remove pressure entirely. Instead, evidence supports interventions that:
- Increase contact area
- Reduce peak interface pressures
- Limit the duration of continuous tissue loading
For diabetic patients, duration of pressure exposure is particularly consequential due to impaired microcirculation. Even pressures tolerated by non-diabetic tissue may become injurious when sustained.
Static vs. dynamic support surfaces in diabetic pressure care
Static surfaces: spatial redistribution
High-specification foam and other static surfaces redistribute pressure across a larger surface area. These surfaces are commonly appropriate for:
- Diabetic patients at low to moderate risk or early stage breakdown
- Individuals who can reposition independently
- Prevention-focused use in ambulatory or semi-mobile patients
Static surfaces reduce peak pressures but do not address time-dependent ischemia.
Dynamic surfaces: temporal redistribution
Dynamic systems—most notably alternating pressure mattresses—redistribute pressure over time by cyclically inflating and deflating air cells. This mechanism:
- Periodically offloads vulnerable tissue
- Promotes intermittent reperfusion
- Reduces prolonged ischemic loading
For diabetic patients with impaired perfusion, this temporal redistribution aligns closely with known pathophysiologic vulnerabilities.
The role of microclimate management
Low air loss (LAL) technology is supported for microclimate control, specifically:
- Reducing excess moisture
- Assisting thermal regulation
- Lowering the risk of maceration
However, the clinical literature does not support LAL as a standalone pressure management solution. LAL addresses skin environment, not pressure duration. In diabetic patients—where both ischemia and moisture contribute to breakdown—microclimate control is supportive but insufficient on its own.
Common misconceptions about support surfaces in diabetic pressure wounds
Non-clinical online content and marketing materials often oversimplify support surface therapy. Common misconceptions include:
“Advanced features automatically improve outcomes.”
There is no evidence that advanced features improve healing without appropriate patient selection and clinical integration.
“Low air loss treats pressure wounds.”
LAL assists with moisture management but does not meaningfully reduce sustained pressure exposure.
“Alternating pressure is uncomfortable.”
Modern systems offer precision control of pressure settings for patient comfort and surface immersion. Patient-sensing technology offers comfort optimization and advanced automated features that target the highest-risk areas, such as the coccyx and heels. Discomfort is more often related to improper settings, patient position, quality of the system, or inappropriate indication.
“One surface works for all diabetic patients.”
Standards of care emphasize risk stratification, not universal solutions.
How alternating pressure aligns with standards of care
Guidance from organizations such as the National Pressure Injury Advisory Panel, the European Pressure Ulcer Advisory Panel, and the Wound, Ostomy and Continence Nurses Society consistently recognizes alternating pressure as appropriate when patients:
- Are at moderate to high risk for pressure injury
- Have existing pressure wounds requiring enhanced redistribution
- Cannot be repositioned frequently or effectively
- Have compromised perfusion, including many diabetic patients
Importantly, alternating pressure is presented as a therapeutic intervention, not a last resort.
Pressure wounds beyond the foot in diabetic patients
While diabetic foot ulcers receive substantial attention, diabetic patients frequently develop pressure wounds at high-risk sites, including:
- Sacrum and coccyx
- Heels
- Ischium
- Trochanters
In bedbound or medically complex patients, these wounds often coexist. Alternating pressure surfaces play an important role in preventing secondary pressure injuries that can complicate healing and prolong hospitalization.
Relationship to repositioning and clinical care
Alternating pressure does not replace repositioning. Standards of care consistently identify it as an adjunctive strategy that:
- Reduces physiologic consequences of unavoidable immobility
- Supports tissue perfusion between repositioning events
- Mitigates risk when turning schedules cannot be perfectly maintained
This is particularly relevant in diabetic patients with acute illness, frailty, or limited tolerance for frequent repositioning.
Clinical implications for practice
For clinicians managing pressure wounds in diabetic patients:
- Match surface selection to risk level and mobility
- Account for the presence of wounds, their location, and severity
- Consider body habitus
- Consider prognosis
- Document clinical rationale for surface choice
- Reassess surface needs as wounds and mobility evolve
Support surfaces should be integrated deliberately into the care plan, not selected reflexively.
Conclusion
Pressure wounds in diabetic patients reflect the intersection of mechanical loading and impaired tissue tolerance. Clinical evidence and consensus guidelines support pressure redistribution—particularly through alternating pressure systems—for appropriately selected patients.
Aligning support surface selection with standards of care requires moving beyond marketing claims toward risk-based, pathophysiology-informed decision-making. When used appropriately, alternating pressure systems serve as a clinically sound adjunct that supports comprehensive pressure wound management in patients with diabetes.
About the Author
Jeff Adise has dedicated more than 28 years to advancing wound care solutions. He is a product specialist and developer of therapeutic support surfaces for the prevention and treatment of pressure injuries across hospital, home, and long-term care settings.
